Psychostimulant use increases anxious behavior, likely through interactions between central corticotropin-releasing factor (CRF) and serotonergic systems. The current study examined whether chronic amphetamine treatment (2.5 mg/kg, 14 days) or withdrawal altered CRF receptor densities in the serotonergic dorsal raphe nucleus (dRN). Amphetamine treatment increased CRF 2 receptor densities in most subregions of the dRN, and CRF 2 receptors were still elevated following 6 weeks of withdrawal. No changes in CRF 1 receptor densities were observed following amphetamine treatment or during withdrawal. Selective increases in dRN CRF 2 receptors may be related to increased anxiety-like behaviors following psychostimulant use. #
The cycle of addiction is thought to be maintained by negative affective symptoms that are manifest upon cessation of drug taking (Koob, 2003) . In rats, withdrawal from chronic psychostimulant administration increases anxiety-like and depressive behaviors (Sarnyai et al., 1995; Perrine et al., 2008) . Corticotropin-releasing factor (CRF) plays an important role in mediating anxiety behavior (Bale, 2005; Shepard and Myers, 2008) . Activation of CRF receptors can increase serotonergic neuronal activity in the dorsal raphe nucleus (dRN) (Lowry et al., 2000; Pernar et al., 2004) and increases serotonin release in forebrain limbic regions important for anxiety-like behaviors (Amat et al., 2004; Forster et al., 2006; Lukkes et al., 2008) . Stress-induced alterations of serotonin release within forebrain limbic regions are suppressed by central CRF receptor antagonism (Price et al., 2002; Mo et al., 2008) . Furthermore, intracerebroventricular administration of CRF antiserum reduces anxiety-like behavior of cocainetreated rats in withdrawal (Sarnyai et al., 1995) . Given the relationship between CRF, serotonin activity and anxiety-like behaviors, psychostimulant-induced changes to CRF receptor levels in the dRN could represent an important pathological alteration related to negative affect following psychostimulant use.
Adult male Sprague Dawley rats (n = 24; University of South Dakota Animal Resource Center) were injected with amphetamine (2.5 mg/kg, i.p.) or saline daily for 14 days. The amphetamine dose and injection schedule were based on preliminary studies showing behavioral sensitization and increased anxiety-like behavior following treatment at 2 weeks withdrawal (Forster et al., 2007) . Twenty hours or 6 weeks following the last injection, rats were anesthetized with pentobarbital (100 mg/kg, i.p.) and transcardially perfused with 0.1 M phosphate-buffered saline followed by 4% paraformaldehyde (n = 6 per treatment group at each time point).
Immunocytochemistry provides spatial resolution/sensitivity, allowing CRF receptor densities within dRN subregions to be analyzed separately (Fig. 1) . Sections of the dRN (30 mm) from saline and amphetamine treated rats were processed together, and consecutive serial sections were processed separately for CRF 1 and CRF 2 receptors, since both receptors are observed in the dRN (Day et al., 2004 
